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Redundant Pathways for Negative Feedback
Regulation of Bile Acid Production
distinct oxysterol 7-hydroxylase (CYP7B) (Axelson et
al., 1992; Payne et al., 1995). These pathways are regu-
lated differently, but negative feedback is a central as-
Li Wang,1 Yoon-Kwang Lee,1 Donnie Bundman,1
Yunqing Han,1 Sundararajah Thevananther,2
Chang-Soo Kim,1 Steven S. Chua,1 Ping Wei,3
pect of the control of both. In this loop, increased bileRichard A. Heyman,3 Michael Karin,4
acid levels result in decreased expression of CYP7A,and David D. Moore1,5
CYP7B, and CYP8B, resulting in decreased bile acid1 Department of Molecular and Cellular Biology
synthesis (Schwarz et al., 1997).2 Department of Pediatrics-Gastroenterology
SHP (NR0B2) is an unusual orphan nuclear receptorBaylor College of Medicine
that contains a putative ligand binding domain but lacks1 Baylor Plaza
a conserved DNA binding domain (Seol et al., 1996).Houston, Texas 77030
SHP can negatively regulate the transcriptional activity3 X-Ceptor Therapeutics, Inc.
of a number of other nuclear receptors (Johansson et4757 Nexus Center Drive
al., 1999; Lee et al., 2000; Masuda et al., 1997; Seol etSuite 200
al., 1996, 1997, 1998). This repression is based on aSan Diego, California 92121
two-step process in which SHP first competes with tran-4 Laboratory of Gene Regulation
scriptional coactivators for binding to the activated li-and Signal Transduction
gand binding domain of its nuclear hormone receptorDepartment of Pharmacology
targets (Johansson et al., 2000; Lee et al., 2000). OnceUniversity of California, San Diego
SHP is recruited to the DNA-bound receptor, its direct9500 Gilman Drive
transcriptional repressor function further decreases ex-La Jolla, California 92093
pression (Lee et al., 2000; Lee and Moore, 2002).
Among the numerous nuclear receptor pathways, sig-
naling by the orphan receptor LRH-1 (NR5A2, alsoSummary
known as FTF) is particularly sensitive to inhibition by
SHP (Lee et al., 1999). A potential role for this repressionThe orphan nuclear hormone receptor SHP has been
in cholesterol metabolism emerged from the identifica-proposed to have a key role in the negative feedback
tion of LRH-1 as an essential factor for cholesterolregulation of bile acid production. Consistent with this,
CYP7A gene expression (Nitta et al., 1999) and the dem-mice lacking the SHP gene exhibit mild defects in bile
onstration that SHP expression is induced by bile acidacid homeostasis and fail to repress cholesterol
activation of another nuclear hormone receptor, FXR7--hydroxylase expression in response to a specific
(Goodwin et al., 2000; Lu et al., 2000). This led twoagonist for the bile acid receptor FXR. However, this
groups to propose a regulatory cascade in which therepression is retained in SHP null mice fed bile acids,
negative feedback regulation of bile acid productiondemonstrating the existence of compensatory repres-
is based on FXR-dependent induction of SHP, whichsion pathways of bile acid signaling. We provide evi-
decreases the ability of LRH-1 to activate CYP7A ex-dence for two such pathways, based on activation of
pression (Goodwin et al., 2000; Lu et al., 2000). Thisthe xenobiotic receptor PXR or the c-Jun N-terminal
model was supported by the demonstration that FXRkinase JNK. We conclude that redundant mechanisms
knockout animals show a complete loss of SHP induc-regulate this critical aspect of cholesterol homeo-
tion and CYP7A repression in response to bile acid feed-stasis.
ing (Sinal et al., 2000).
While this SHP-dependent regulatory cascade ele-
Introduction
gantly accounts for the inhibitory effects of bile acids
on their own synthesis, several lines of evidence suggest
Cholesterol accumulates due to both de novo synthesis that other pathways are also involved. Perhaps the most
and dietary ingestion and is primarily lost by conversion direct is the fact that the bile acid repression of other
to bile acids. Control of the rate of conversion of choles- negatively regulated target genes, such as CYP8B, is
terol to bile acids is therefore of critical importance in unaffected by the loss of the FXR gene (Sinal et al.,
maintaining overall sterol balance (Dietschy and Turley, 2000). In addition, several reports suggest that CYP7A
2002). At least two pathways of bile acid biosynthesis expression can be repressed as a consequence of bile
have been described in the mammalian liver. The major acid activation of other signaling pathways. These in-
neutral pathway is initiated in the endoplasmic reticulum clude activation of the xenobiotic receptor PXR, a nu-
by the cytochrome P450 enzyme cholesterol 7-hydrox- clear hormone receptor that is generally associated with
ylase (CYP7A) (Chiang, 1998; Russell and Setchell, 1992; drug metabolism but that can also be activated by par-
Schwarz et al., 1998). This is the rate-limiting step in ticularly toxic bile acids (Staudinger et al., 2001; Xie et
this pathway. Therefore, regulation of CYP7A expression al., 2001). This activation results in induction of the broad
is a key factor in cholesterol homeostasis. The additional specificity cytochrome P450 CYP3A, which can metabo-
acidic pathway is initiated in the mitochondria by the lize the toxic bile acids to less toxic forms. Bile acid
enzyme sterol 27-hydroxylase (CYP27), followed by a activation of PXR results in repression of CYP7A (Stau-
dinger et al., 2001) via as yet unidentified mechanisms.
Specific bile acids have also been found to activate5 Correspondence: moore@bcm.tmc.edu
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Figure 1. Targeted Disruption of the SHP
Gene and Generation of SHP Null Mice
(A) Map of targeting vector for homologous
recombination (top) and the SHP gene (bot-
tom). Targeted deletion of the first exon of
SHP gene and its replacement with the -gal
and pGKneo cassette was done using the
targeting vector. Restriction enzyme sites as
well as the probe used to screen for homolo-
gous recombination by Southern blotting are
indicated.
(B) Southern blot analysis of mouse tail geno-
mic DNA digested with StuI for wild-type
(/), heterozygous (/) and homozygous
(/) animals. A 2 kb genomic fragment is
indicative of the wild-type allele, and a 7 kb
fragment is indicative of the null allele.
(C) Northern blot analysis of mouse liver SHP
mRNA expression. Hepatic total RNA (10 g)
was probed with a 32P-labeled SHP cDNA
probe. Ribosomal 28 S RNA was used as
loading control.
stress kinase signaling pathways, specifically, JNK Results
(c-Jun N-terminal kinase) signaling. Inhibition of this re-
sponse decreases the ability of these bile acids to re- Generation of SHP Null Mice
Gene targeting in embryonic stem cells was used topress CYP7A expression (Gupta et al., 2001).
A direct prediction of the nuclear receptor regulatory generate SHP-deficient mice. The mouse SHP gene con-
sists of two exons and one intron (Lee et al., 1998), andcascade, but not other potential mechanisms, is that
loss of SHP function should result in abrogation of nega- a targeting construct was generated by replacing exon
1 with a -galactosidase/pGKneo cassette (Figure 1A).tive feedback. To evaluate the contribution of SHP to
bile acid feedback regulation and other pathways, we Germline transmission was obtained with two indepen-
dent recombinant ES clones, and heterozygous F1 ani-generated mice with a targeted disruption of the SHP
gene. Homozygous null SHP/ animals are viable and mals were crossed to generate homozygous SHP/
mice. The genotype of these mice was confirmed byfertile and show no major defects in cholesterol metabo-
lism under ordinary circumstances. As predicted by the Southern blot analysis (Figure 1B) and PCR. Northern
blotting demonstrated that no SHP transcripts are ex-nuclear receptor cascade, the ability of the synthetic
FXR agonist GW4064 to repress CYP7A expression in pressed in the livers of SHP/ mice, while SHP tran-
scripts are decreased by approximately 50% in SHP/wild-type mice is completely lost in the SHP null animals.
When challenged with a diet containing bile acids, how- heterozygous mice (Figure 1C). SHP null mice were gen-
erated at the predicted Mendelian frequency and areever, CYP7A repression was observed in both wild-type
and SHP null mice, demonstrating the importance of viable and fertile. They do not exhibit any overt pheno-
type when reared under normal conditions.additional negative regulatory pathways. Further studies
suggest that both the JNK and PXR pathways may be
involved in CYP7A repression by bile acids in the SHP Bile Acid Negative Feedback Regulation
in SHP Null Micenull animals. Overall, these results confirm the potential
of the SHP-dependent nuclear receptor cascade to re- A clear prediction of the proposed role of SHP in the
nuclear receptor cascade for feedback repression ofpress CYP7A production in vivo and demonstrate that
additional pathways exist to control this central aspect CYP7A is that such repression should be absent in SHP
null animals, as is observed for FXR null animals (Sinalof cholesterol homeostasis.
Bile Acids Repress CYP7A Expression in SHP/ Mice
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Figure 2. Northern Blot and Real-Time PCR
Analysis of Genes Involved in Bile Acid Bio-
synthesis
Wild-type and SHP null mice (/) were fed
a control diet (CON) or a diet supplemented
with 1% cholic acid (CA) for 7 days.
(A) Northern blot analysis of mRNA expres-
sion. Equal amounts of total liver RNA were
pooled from five to seven mice in each group.
Twenty micrograms of the pooled sample
were resolved and hybridized with the indi-
cated 32P-labeled cDNA probes.
(B) Real-time quantitative PCR analysis of
CYP7A mRNA expression. Total liver RNA
was isolated from SHP (/) and (/) and
pooled from an average of five mice per
group. Q-PCR results were normalized with
TaqMan Ribosomal RNA control. Each group
was performed in triplicate.
(C) Groups of five SHP (/) and (/) mice
were fed the FXR agonist GW 4064 or the
RXR agonist LG100268 by oral gavage for
one day. Equivalent amounts of total liver
RNA were pooled, and 20 g was resolved
and probed with 32P-labeled CYP7A or-actin
cDNA probes.
et al., 2000). To test this, wild-type and SHP null mice CA-fed SHP null animals (Figure 2B). The increases in
CYP7A expression observed in both the control andwere fed a diet supplemented with 1% cholic acid (CA)
for 7 days. As shown in Figure 2A, SHP mRNA was CA-fed SHP/ mice relative to the wild-type mice are
consistent with the proposed negative feedback role ofabsent in SHP/ mice but was induced approximately
3-fold by CA feeding in wild-type mice. Expression of SHP. However, the strong repression observed in the
SHP/ animals demonstrates the existence of signalingCYP7A, CYP8B, and CYP27 mRNAs was not markedly
different in wild-type and SHP/ mice on the control pathways that allow bile acids to repress CYP7A, even
in the absence of SHP.diet, but CYP7B expression was significantly decreased
in the SHP/ animals. As expected, the expression of These results raise questions regarding the impor-
tance of SHP in bile acid negative feedback regulation.CYP7A, CYP7B, and CYP8B was virtually undetectable
in the CA-fed wild-type mice. Unexpectedly, however, To more directly test the role of SHP in the proposed
nuclear receptor regulatory cascade, we fed both wild-very efficient repression of these three bile acid biosyn-
thetic enzymes was also observed in the SHP/ mice. type and SHP null mice the specific FXR agonist
GW4064 (Willson et al., 2001) (GW) or the RXR agonistCYP27 expression was not affected by CA feeding. The
expression of LRH-1 was also not different in control LG100268 (Boehm et al., 1995) (LG) by oral gavage.
As expected from the results described above, CYP7Aor CA-fed SHP/ and SHP/ mice (data not shown),
suggesting that it is not directly regulated by bile acid mRNA expression was not markedly different in un-
treated wild-type and SHP/ mice. Consistent with pre-levels.
Quantitative real-time PCR (Q-PCR) was used to more vious results, feeding either the FXR or RXR agonist
blocked CYP7A expression in wild-type mice (Goodwinaccurately assess the bile acid feedback repression of
CYP7A in the wild-type and SHP/ animals. In animals et al., 2000; Lu et al., 2000; Repa and Mangelsdorf, 2000).
In striking contrast to the results with bile acid feeding,fed the normal chow diet, CYP7A levels were approxi-
mately 50% higher in the SHP null animals than in the however, this repression was completely absent in
SHP/ mice (Figure 2C). Thus, activation of either FXRwild-types. In the CA-fed wild-type animals, CYP7A ex-
pression levels were very strongly repressed. As ob- or RXR results in repression of CYP7A expression by
a pathway that requires SHP. The potent repressionserved in the Northern blots, however, low but detect-
able levels of CYP7A expression were observed in the observed in response to bile acid feeding in the SHP/
Developmental Cell
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Figure 3. Bile Acid Homeostasis in SHP Null
Versus Wild-Type Mice
Bile acid homeostasis in SHP null versus wild-
type mice fed a control diet (CON) or a diet
supplemented with 1% cholic acid (CA) for 7
days.
(A) Change of body weight of SHP (/) and
(/) mice fed control or CA diet.
(B) Liver mass relative to total body mass of
SHP (/) and (/) mice fed control or CA
diet.
(C) Bile acid pool size of SHP (/) and (/)
mice fed control or CA diet.
(D) Bile acid excretion of SHP (/) and (/)
mice fed control or CA diet. All values are
expressed as mean SEM, n  5–10. Signifi-
cant differences compared to wild-type mice
on the same diet are indicated by asterisks
(p  0.05).
mice must be based on one or more additional, redun- SHP/ mice compared with wild-type mice fed the con-
trol diet but decreased by 2-fold in SHP/ mice com-dant pathways.
pared with wild-type mice fed the CA diet (Figure 3C).
There was no significant difference in bile acid excretionAlteration of Bile Acid and Cholesterol
Homeostasis in SHP Null Mice in mice of either genotype on the control diet. As ex-
pected, the rate of bile acid excretion increased stronglyA number of parameters were assessed to further ex-
plore potential defects in bile acid and cholesterol ho- in the wild-type mice on the CA diet. Consistent with the
change in bile acid pool size, the SHP/ mice showed ameostasis in the wild-type and SHP null animals. As
shown in Figure 3A, wild-type and SHP/ mice exhib- less marked increase, resulting in a significantly de-
creased rate of excretion relative to the wild-type miceited normal weight gain and growth on the control diet.
However, both wild-type and SHP null mice exhibited a (Figure 3D). Overall, these results demonstrate that the
loss of SHP results in defects in bile acid homeostasis.dramatic decrease in body weight in the first two days
of CA feeding. After that, the wild-type mice appeared The primary pathway for catabolic elimination of cho-
lesterol is conversion to bile acids. Therefore, we alsoto tolerate the CA diet well, and body weight showed
no further decrease, whereas the SHP/mice displayed examined the homeostatic control of cholesterol and
other lipids in the SHP null mice. As shown in Figurea continued decrease in body weight. Liver to body
weight ratios were similar for both SHP/ and SHP/ 4A, no differences were observed for hepatic cholesterol
content, regardless of diet. However, the serum choles-mice fed the control diet but increased similarly upon
CA feeding (Figure 3B). Histological examination of the terol level decreased by approximately 30% in SHP/
mice relative to wild-type mice upon CA feeding (Figurelivers by hematoxylin and eosin staining revealed no
signs of abnormal hepatotoxicity for either genotype on 4B). Though there were no significant differences in he-
patic triglyceride content for wild-type or SHP null micethe control or CA diet (data not shown).
On the control diet, total serum bile acid concentration on the control diet, CA feeding markedly reduced he-
patic triglyceride content in wild-type mice but had awas about 2.3-fold greater in SHP/ mice than in wild-
type mice. However, serum bile acid concentration in- lesser effect in SHP/ mice. This resulted in a 2.3-fold-
higher level of hepatic triglycerides in SHP/ mice thancreased much more markedly in wild-type mice than in
SHP/ mice fed 1% CA, resulting in a 2.7-fold-higher in wild-type mice (Figure 4C). The serum triglyceride
levels followed the changes in hepatic triglyceride con-serum bile acid concentration in the wild-type mice than
in the SHP/ mice (data not shown). We further ana- tent (Figure 4D). CA feeding resulted in decreased he-
patic as well as serum free fatty acid concentration inlyzed the bile acid pool size and fecal bile acid excretion
rates. Bile acid pool size was increased by 1.6-fold in both wild-type and SHP/mice compared to the control
Bile Acids Repress CYP7A Expression in SHP/ Mice
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Figure 4. Lipid Homeostasis in SHP Null Ver-
sus Wild-Type Mice
Hepatic and serum cholesterol (A and B), tri-
glycerides (C and D), and free fatty acid (E
and F) concentrations were measured in SHP
(/) and (/) mice fed control or CA diet.
All values are expressed as meanSEM, n
5–10. Significant differences compared to
wild-type mice on the same diet are indicated
by asterisks (p  0.05).
diet, but no significant differences were observed be- canalicular bile salt exporter, which is expressed at low
levels in the wild-type animals. These increases confirmtween the two genotypes (Figures 4E and 4F). Together,
these data suggest that SHP null mice have mild defects the function of SHP as a regulator of bile acid metabo-
lism, although it remains possible that they are second-in lipid homeostasis.
A combination of Northern blot and Q-PCR analysis ary to the increased bile acid pool size rather than a
direct effect of loss of SHP on BSEP or NTCP promoterwas used to determine whether hepatic expression of
a number of genes involved in bile acid and cholesterol activity. CA feeding repressed expression of NTCP, as
expected. As with the bile acid biosynthetic enzymes,homeostasis is affected by the deletion of the SHP gene
(Figure 5). FXR expression was not different in the this repression was also observed in the SHP null ani-
mals. BSEP expression was strongly induced by bileSHP/ animals than in the wild-type animals on the
control diet but was decreased in both by approximately acid feeding in the wild-type animals. In the SHP null
mice, however, CA feeding did not significantly increase60% in response to CA feeding. The expression of two
bile acid transporters, the sodium-taurocholate cotrans- BSEP expression above the high basal levels.
The expression of three important targets for choles-porter protein (NTCP) and the bile salt export pump
(BSEP) were both increased in the SHP/ animals on terol homeostasis, HMG-CoA synthase, HMG-CoA re-
ductase, and the LDL receptor, was decreased in thethe control diet, consistent with a repressor function for
SHP. This was particularly evident for BSEP, the major SHP null animals on the normal diet (Figures 5A–5C).
Developmental Cell
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Figure 5. Northern Blot and Q-PCR Analysis
of Expression of Genes Involved in Choles-
terol and Bile Acid Metabolism
Groups of five to seven wild-type (/) or
SHP (/) mice were fed control diet (CON)
or a diet supplemented with 1% cholic acid
(CA) for 7 days. Equal amounts of total liver
RNA were pooled from the mice in each
group.
(A) Northern blot analysis of mRNA expres-
sion. Twenty micrograms of the pooled sam-
ple was resolved and hybridized with the indi-
cated 32P-labeled cDNA probes.
(B) Real-time quantitative RT-PCR analysis
of mRNA expression. Total liver RNA of SHP
(/) and (/) mice was used for Q-PCR
analysis. Values were normalized with Taq-
Man Ribosomal RNA Control. Each group
was performed in triplicate.
These three genes are coordinately regulated by SREBP The PXR Signaling Pathway Is Involved in Bile Acid
Homeostasis in SHP Null Miceisoforms in response to cholesterol levels, but hepatic
cholesterol levels do not differ in the control-fed wild- The pregnane X receptor (PXR) is an important compo-
nent of the xenobiotic response, which protects thetype and null animals, and levels of both SREBP-1 and
LXRwere also unaltered in the control-fed SHP/mice body from harmful exogenous chemicals. A function for
PXR in bile acid homeostasis was suggested by the(Figures 5D and 5E). Thus, the decreased expression of
HMG-CoA synthase, HMG-CoA reductase, and the LDL demonstration that it can also be activated by bile acids,
particularly, lithocholic acid and other toxic bile acidsreceptor in the SHP null animals must be secondary to
another regulatory signal that may be related to the (Staudinger et al., 2001; Xie et al., 2001). The potential
importance of this function was supported by the obser-increased bile acid pool.
CA feeding dramatically reduced expression of all vation that non-bile acid PXR activators, such as the
steroid PCN, significantly decrease CYP7A expressionthree genes in the wild-type animals. This presumably
reflects the decreased need for cholesterol due to the (Staudinger et al., 2001). To determine whether this alter-
native pathway for bile acid repression of CYP7A isdecrease in its conversion to bile acids. However, this
response was absent in the SHP/ animals, which also active in the SHP null animals, we examined the expres-
sion of PXR and several of its known target genes inshow strong repression of CYP7A and other bile acid
biosynthetic enzymes. The increased expression in the the SHP/ animals.
On the control diet, expression of one of the severalCA-fed SHP/ mice may be a reflection of their in-
creased expression of SREBP-1 relative to the wild-type PXR transcripts was somewhat higher in SHP null ani-
mals than in wild-type animals, suggesting an additionalanimals. The basis for this increased SREBP-1 expres-
sion is not clear. The SHP/ animals also show a mod- negative regulatory role for SHP (Figure 6). CA feeding
modestly increased expression of both this transcriptestly decreased expression of LXR relative to the wild-
type animals. This expression is increased in response and a lower molecular weight mRNA in both wild-type
and knockout animals. On the control diet, the loss ofto CA in both the wild-type and knockout animals.
Bile Acids Repress CYP7A Expression in SHP/ Mice
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Figure 6. Northern Blot Analysis of mRNA
Expression
Wild-type (/) and SHP (/) mice were
fed a control diet (CON) or a diet supple-
mented with 1% cholic acid (CA) for 7 days.
Twenty micrograms of the pooled sample
were resolved and hybridized with the indi-
cated 32P-labeled cDNA probes. The RNA in
this study is the same as in Figure 5.
SHP did not significantly affect basal expression of the CA treatment modestly decreased CYP7A expression
in both wild-type and SHP/ hepatocytes. Relative toprimary PXR targets CYP3A11, CYP2B10, or MDR1.
However, the strong induction of all three genes in the the untreated cells, this repression was blocked by the
addition of SP in both wild-type and SHP null hepato-CA-fed animals suggests that PXR is activated under
these conditions. These results support the possibility cytes, although CA treatment did decrease expression
relative to levels observed with SP alone in both cases.that PXR activation contributes to the observed bile acid
repression of CYP7A expression in the SHP null animals. These results indicate that JNK activation results in
CYP7A repression by a pathway that is quite distinct
from the nuclear receptor-mediated pathways.
The JNK Signaling Pathway Is Involved in Bile Acid
Repression of CYP7A in SHP Null Mice
There is growing evidence suggesting that activation of Discussion
the JNK signaling pathway also contributes to feedback
repression of CYP7A by bile acids. This is primarily Cholesterol homeostasis is maintained by the coordi-
nate regulation of cholesterol biosynthesis, cholesterolbased on results in isolated primary hepatocytes, where
this kinase has been shown to be specifically activated uptake from plasma, and cholesterol catabolism in the
liver (Brown and Goldstein, 1997; Russell, 1999; Chawlaby bile acids (Gupta et al., 2001). To determine whether
JNK is also activated by bile acid treatment in vivo, wild- et al., 2001). The conversion of cholesterol to bile acids
represents a major pathway for its elimination from thetype and SHP/ mice were fed the control or CA diets
for 1 week, and activation was assessed using an anti- body (Chiang, 1998; Russell and Setchell, 1992), and
two pathways for bile acid biosynthesis have been de-body specific for phosphorylated, active JNK. As ex-
pected from the results in hepatocytes, the p54 JNK-2 scribed. Cholesterol 7-hydroxylase (CYP7A) has been
characterized as the rate-limiting enzyme in the neutralisoform was activated in livers of CA-fed mice (Figure
7A). This activation was not affected by the presence (classic) pathway (Chiang, 1998). The initial enzyme in
the acidic pathway is sterol 27-hydroxylase (CYP27),or absence of functional SHP.
A recently described specific inhibitor of JNK activa- which is followed by oxysterol 7-hydroxylase (CYP7B)
(Axelson et al., 1992; Payne et al., 1995). Expression oftion, SP600125 (Han et al., 2001) (SP), was used to deter-
mine the effect of this JNK activation on CYP7A mRNA CYP7A, CYP7B, and other enzymes in the pathway is
strongly repressed by high levels of bile acids, and theexpression. Since this inhibitor has a very short half-life
in mice, these experiments used primary hepatocytes, response of CYP7A has been particularly well studied.
Based on both its induction by activated FXR and itswhich show a much less effective repression of CYP7A
expression than that observed in liver. Basal CYP7A ability to repress the function of LRH-1, SHP has been
proposed to be a key component of a nuclear receptorexpression was 2-fold higher in the SHP/ hepatocytes
than in the wild-type cells (Figure 7B), as expected from cascade that is responsible for the repression of CYP7A
expression by bile acids (Goodwin et al., 2000; Lu et al.,the results described above. This basal expression was
increased by SP treatment, particularly in the wild-type 2000).
As observed with several other genetic perturbationsanimals. This increase is consistent with the proposed
negative effect of activated JNK on CYP7A expression. (Dietschy and Turley, 2002), cholesterol homeostasis is
Developmental Cell
728
Figure 7. Cholic Acid Feeding Induces JNK
Activation
(A) Total liver homogenates (10 g) were ana-
lyzed by Western blotting with antibodies
specific for phospho-JNK (1:2000) (upper
panel) and JNK (1:2000) (lower panel).
(B) Real-time quantitative RT-PCR analysis
of hepatocyte mRNA isolated from wild-type
and SHP null mice. Primary hepatocytes from
SHP (/) and (/) mice were cultured with
or without 100M CA or 20M of the specific
JNK inhibitor SP 600125 (SP) for 20 hr. Total
RNA was isolated, and used for Q-PCR analy-
sis with primers specific to CYP7A gene. Val-
ues were normalized with TaqMan Ribosomal
RNA Control. Each experiment was repeated
three times in triplicate. Results are the aver-
age of three experiments.
not grossly affected by the loss of SHP, as demonstrated CYP7A expression is still observed in the bile acid-fed
SHP knockout animals. We conclude that SHP doesby the lack of effects on hepatic or serum cholesterol
levels. However, a general function for SHP in bile acid function in an FXR-dependent negative regulatory path-
way but that bile acid feeding activates additional, re-metabolism is suggested by the increased bile acid pool
observed in the control-fed SHP null mice, as well as dundant mechanisms for repression.
The function of SHP in the nuclear receptor cascadethe alterations in basal expression of CYP7A, NTCP,
and, particularly, BSEP. The failure of these alterations is based on its induction in response to FXR activation.
However, the relatively modest 2–5-fold induction ofto alter cholesterol levels is presumably a consequence
of compensatory changes in expression of other key SHP mRNA expression in response to bile acids or syn-
thetic FXR agonists contrasts with the essentially com-proteins, such as the decreased expression of HMG-
CoA reductase and the LDL receptor. plete repression of CYP7A expression that is observed
in vivo. Indeed, the increase in SHP mRNA levels in theThe importance of SHP in bile acid negative feedback
regulation is strongly supported by the demonstration GW4064-treated animals described here was less than
2-fold, suggesting that additional mechanisms, such asthat the efficient repression of CYP7A expression in
wild-type animals treated with specific ligands for either induction of factors that modulate SHP activity, may be
involved in the FXR-dependent repression of CYP7AFXR or RXR is completely lost in SHP null animals. The
absence of SHP also results in modest increases in expression. Additional pathways beyond those depen-
dent on FXR are also required to account for the obser-CYP7A mRNA in untreated and cholic acid-fed animals.
In contrast to the predictions of the proposed nuclear vation that loss of the FXR gene results in loss of bile
acid repression of CYP7A and CYP8B but does not af-receptor cascade, however, a substantial repression of
Bile Acids Repress CYP7A Expression in SHP/ Mice
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kb pGKneo gene cassette. The targeting vector was linearized withfect bile acid repression of CYP7B expression (Sinal et
NotI and electroporated into embryonic stem (ES) cells derived fromal., 2000).
129 mouse blastocysts. Clones that were resistant to G418 (LifeAt least two such additional pathways have been iden-
Technologies) were picked and screened for homologous recombi-
tified, the first of which is based on the xenobiotic recep- nation by Southern blotting of StuI-digested genomic DNA. Out of
tor PXR. Previous results have demonstrated that toxic 600 clones, 9 were selected and further verified by 5	 and 3	 arm
PCR and Southern blot analysis. Blastocysts from C57B1/6 micebile acids, such as lithocholic acid, are ligands for this
were injected with six different ES clones and implanted into pseu-receptor (Staudinger et al., 2001; Xie et al., 2001). Its
dopregnant foster mothers. Several chimeric male pups were ob-activation induces CYP3A expression, resulting in hy-
tained and mated with C57B1/6 females. Germline transmissiondroxylation and detoxification of such compounds. Spe-
was obtained with two independent ES clones, and heterozygote
cific PXR activation by the catatoxic steroid pregneno- offspring were intercrossed to obtain animals homozygous for the
lone 16-carbonitrile also results in repression of CYP7A SHP deletion. Genotyping was performed by multiplex PCR analysis
of genomic DNA obtained from tail snips and confirmed by Northernexpression via unknown mechanisms (Staudinger et al.,
blotting of liver RNA and Southern blotting of genomic DNA isolated2001; Repa and Mangelsdorf, 2000). Although cholic
from the tail. Primers used to detect the KO allele were sense, Gal-acid itself is not an effective activator of murine PXR,
PCR 5	 (5	-CTAGCTAGAGGATCCCCGGGTACC-3	) and antisense,metabolism of cholic acid by the gut flora would be
Gal-PCR 3	 (5	-AATTCGCGTCTGGCCTTCCTGTAG-3	), located in
expected to generate a variety of secondary bile acids. the -gal cassette. Primers used to detect the wild-type allele were
Consistent with this, cholic acid feeding resulted in sense, Exon-1F (5	-CTCTGCAGGTCGTCCGACTATTCTG-3	) and
antisense, Exon-1B (5	-CCTCGAAGGTCACAGCATCCTG-3	), lo-strong activation of three PXR target genes, CYP3A11,
cated in the deleted first exon of the SHP gene coding region.CYP2B10, and MDR1, in both wild-type and SHP null
These animals were used in subsequent studies with the animalsanimals. We conclude that PXR is activated in these
maintained with a C57B1/129sv hybrid background. All protocolsanimals and that this activation likely contributes to the
for animal use and euthanasia were approved by the Animal Care
observed repression of CYP7A by bile acids. Committee at Baylor College of Medicine and were in accordance
An additional negative regulatory pathway was sug- with NIH guidelines.
gested by recent results linking JNK activation to CYP7A
repression in primary rat hepatocytes (Gupta et al., Mouse Studies
Unless otherwise indicated, mice were housed four to six per cage2001). In these studies, bile acids were found to activate
in a temperature-controlled room (23
C) in virus-free facilities on ap54/JNK-2, and specific inhibition of this activity re-
12 hr light/dark cycle (0700 on, 1900 off) and were fed a standardsulted in decreased repression of CYP7A. We have con-
rodent chow (no. 5001, Test Diet) and water ad libitum. Age- and
firmed that cholic acid feeding increases levels of the sex-matched groups of 8- to 12-week-old wild-type and SHP/
active, phosphorylated JNK in vivo and also demon- mice were used in all the experiments. Bile acid feeding experiments
strated that treatment of primary hepatocytes with the were performed with experimental diets consisting of the control
diet supplemented with 1% (w/w) cholic acid (CA). Mice were fedspecific JNK inhibitor SP600125 results in increased
for 7 days. After 4 days on the special diet, mice were placed inCYP7A expression in both the presence and absence
individual Metabowl cages for collection of feces for 72 hr. At theof bile acids. These effects are blunted, but not elimi-
end of the feeding, mice were fasted overnight (15 hr), and blood
nated, in hepatocytes from SHP/ mice, indicating that was collected from the orbital plexus after mice were anaesthetized
SHP may be a component of the JNK pathway. This is with avertin. Tissues not used for histology were weighed, sectioned,
consistent with the observation that the SHP promoter and snap frozen in liquid nitrogen and stored at 80
C until use.
For FXR and RXR agonist treatment experiment, FXR agonistcontains an AP-1 site and can be transactivated by c-jun
GW4064 (GW) and RXR agonist LG100268 (LG) were obtained from(Gupta et al., 2001), a major target of JNK mediated
X-Ceptor Therapeutics (San Diego, CA). Both compounds were dis-phosphorylation (Hibi et al., 1993; Kallunki et al., 1994).
solved in corn oil and administered by gavage at 30 mg/kg body
The residual repression of CYP7A expression by cholic weight either twice (GW) or once (LG) for one day. Mice were exsan-
acid in the SP600125-treated SHP/ hepatocytes sug- guinated 24 hr following the treatment. Liver total RNA was extracted
gests the existence of pathways beyond those depen- and used for Northern blotting analysis.
dent on JNK activation and SHP function. However, we
Northern and Southern Blot Analysisconclude that the JNK pathway is a potential contributor
Total RNA was isolated from liver or hepatocytes as indicated usingto the bile acid-dependent repression of CYP7A expres-
Tri-reagent (Invitrogen) according to the manufacturer’s instruc-sion in both wild-type and SHP/ animals.
tions. For Northern blot analysis, 10 or 20 g of RNA was denatured,
Overall, these results establish a role for SHP in bile electrophoresed, transferred to nylon membrane, and probed with
acid metabolism and demonstrate the existence of re- different cDNA probes. RNA samples were processed as previously
dundant pathways to regulate this critical aspect of cho- described (Wang et al., 2001). All the cDNA probes used in this
study were prepared by RT-PCR using primers designed from eachlesterol homeostasis. The availability of SHP null animals
gene’s mRNA sequence obtained from GenBank. For Southern blotwill allow these additional mechanisms to be character-
analysis, genomic DNA was isolated and processed as describedized in the absence of the SHP pathway and will also
(Wang et al., 2001).
facilitate the exploration of additional SHP functions.
Hepatocyte Culture
Hepatocytes were isolated using a modification of the collagenaseExperimental Procedures
perfusion method (Berry and Friend, 1969) and further purified by
Percoll gradient centrifugation. The cells were suspended in DMEMTargeting Vector and Generation of SHP-Deficient Mice
SHP BAC clones were isolated from a mouse 129SVJ genomic li- plus 10% charcoal-stripped serum and plated in Matrigel (Discovery
Labware, Bedford, MA)-coated 6 cm plates with a cell density ofbrary (Genome Systems, St. Louis). Two genomic DNA fragments,
a 1.3 kb promoter fragment and a 4.5 kb fragment containing the 1–2  106 viable cells. Two hours later, the medium was replaced
with William’s E medium (Life Technologies) containing 3  108 MSHP intron and the second exon, were inserted into a pBlue-
scriptSK (Stratagene) -gal/pGKneo vector so that 0.57 kb of the selenium, 10 mg/l insulin, 10 mg/l transferrin, 1  107 M somato-
tropin, 1  106 M T3, 1  106 M dexamethasone (DEX), 50 g/lfirst exon of the SHP gene was replaced by a 3.5 kb -gal and 1.8
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EGF, and 25 mg/l gentamycin. Twenty-four hours later, cells were levels were determined by BCA protein assay method according
to the manufacturer’s instructions (Pierce Chemical, Rockford, IL).treated with medium containing 100 M CA or the JNK-specific
inhibitor SP 600125 (Han et al., 2001) at a final concentration of 20 Protein samples were resolved by 10% SDS-PAGE and transferred
to Tran-Blot Transfer membrane (Bio-Rad, Hercules, CA) at 250 mAM for 20 hr. The cells were harvested and used for RNA isolation.
for 75 min. Membranes were blocked (1 hr at room temperature) in
5% nonfat dry milk dissolved in TBST (Tris-buffered saline Tween)Real-Time Quantitative PCR
prior to incubation with antibodies specific for phospho-JNKA one-step real-time reverse transcription (RT) PCR technique was
(1:2000; Cell Signaling Technology, Beverly, MA) or JNK (1:2000;applied to determine the relative expression levels of mRNA using
Cell Signaling Technology, Beverly, MA) for 16 hr at 4
C. Antibodiesthe ABI Perkin Elmer Prism 7700 Sequence Detection System (Ap-
were diluted in 5% BSA in TBST. Membranes were subsequentlyplied Biosystems). Total RNA was prepared from appropriately
washed with TBST three times and incubated with secondary anti-treated livers or hepatocytes. The reaction mix included from 50
body (anti-rabbit goat IgG linked with horseradish peroxidase,nM–300 nM final concentration of forward and reverse gene-specific
1:2000, in 5% milk in TBST) for 1hr at room temperature. Afterprimers as optimized for each gene and a 100 nm final concentration
washing in TBST three times, blots were incubated with ECL re-of the gene specific probe labeled with FAM reporter fluorescent
agents for 1 min according to the manufacturer’s instructions (West-dye. Primer sequences were kindly provided by Dr. Brandee
ern Lightning Chemiluminescent Reagent Plus; PerkinElmer LifeWagner. A one-step reaction mixture provided in the Taqman One-
Sciences, Boston, MA).step RT-PCR Master Mix Reagents Kit (PE Applied Biosystems) was
used for all amplifications. Cycle parameters for the one-step RT-
AcknowledgmentsPCR included a reverse transcription step at 48
C for 30 min, fol-
lowed by 40 cycles of 95
C denaturation and 60
C annealing/exten-
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to D.D.M.and repeated at least three times. Data are expressed as the means
SEM. The sequences of primers were as follows: SHP forward,
5	-GTACCTGAAGGGCACGATCC-3	; SHP reverse, 5	-AGCCTCCT Received: March 12, 2002
GTTGCAGGTGT-3	; CYP7A forward, 5	-GCTTGTAGAGAGCCACAC Revised: April 12, 2002
CAA-3	; CYP7A reverse, 5	-AGTGGTGGCAAAATTCCCA-3	; HMG-
CoA reductase forward, 5	-TTCTGGCAGTCAGTGGGAACT-3	; HMG- References
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reverse, 5	-CCATGCACAGGGTCCACTA-3	; LXR forward, 5	-GAA Cholesterol is converted to 7 alpha-hydroxy-3-oxo-4-cholestenoic
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Berry, M.N., and Friend, D.S. (1969). High-yield preparation of iso-
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